Market Overview

Goldman Sachs Initiates Solazyme With A Buy


Goldman Sachs is initiating coverage on Solazyme, Inc. (NASDAQ: SZYM) with a Buy rating and a $31 price target.

In a note to clients, Goldman Sachs writes, "We initiate coverage of Solazyme with a Buy rating and a $31, 12-month price target, driven by new capacity and product commercialization that should lessen the risk profile. Solazyme produces oils by feeding sugar to algae in a fermentation process. Without subsidies, we think Solazyme's tailored oils can sustain higher margins relative to commodity, plant-based oils. We view the main near-term market opportunity as oleochemicals, but with additional opportunities in food, skin care, diesel, and jet fuel. We modestly forecast 2011/2012/2013 revenue of $46 mn/$55 mn/$164 mn and adjusted EPS of ($0.78)/($0.70)/($0.12), with cash-flow breakeven in 2014."

Shares of SZYM gained 79 cents yesterday to close at $24.50, a gain of 3.33%.

Posted-In: Goldman SachsAnalyst Color Price Target Initiation Analyst Ratings


Related Articles (SZYM)

View Comments and Join the Discussion!

Latest Ratings

View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

KBW Initiates AerCap Holdings at Outperform

Compuware Acquires dynaTrace software for $256M